Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of FABP4 (unknown origin) at 10 uM
Assay data:10 Tested
SummaryRelated BioAssays by Target
Displacement of BODIPY 500/510 C4 from human FABP4 expressed in Escherichia coli incubated for 30 mins by FP assay
Assay data:2 Active, 4 Tested
Binding affinity to human FABP4 expressed in Escherichia coli assessed as degree of fluorescent shift by temperature-dependent fluorescence thermal shift assay
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
Binding affinity to FABP4 (unknown origin) assessed as inhibition constant
Assay data:6 Active, 1 Activity ≤ 1 nM, 5 Activity ≤ 1 µM, 10 Tested
Inhibition of human FABP4
Assay data:6 Active, 5 Activity ≤ 1 µM, 6 Tested
Inhibition of recombinant human FABP4
Assay data:5 Active, 2 Activity ≤ 1 µM, 21 Tested
Inhibition of FABP4 (unknown origin) by fluorescence polarization assay
Assay data:20 Active, 3 Activity ≤ 1 µM, 28 Tested
Inhibition of FABP4 (unknown origin)
Assay data:20 Active, 16 Activity ≤ 1 µM, 20 Tested
Inhibition of human FABP4 assessed as inhibition constant by fluorescent displacement assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of FABP4 (unknown origin) assessed as inhibition constant
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of FABP4 (unknown origin) incubated for 10 mins by fluorescence based analysis
Assay data:5 Active, 5 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Assay data:2 Active, 2 Tested
Displacement of 1,8-ANS from human recombinant FABP4 incubated for 4 mins by fluorescence based analysis
Assay data:1 Active, 1 Tested
Fluorescent Displacement Assay from US Patent US10709688: "Agent for treating synucleinopathy"
Assay data:16 Active, 10 Activity ≤ 1 µM, 16 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay from US Patent US9353102: "Non-annulated thiophenylamides"
Assay data:42 Active, 40 Activity ≤ 1 µM, 42 Tested
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay from US Patent US9278918: "Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors"
Assay data:16 Active, 14 Activity ≤ 1 µM, 16 Tested
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay from US Patent US9604977: "Bicyclic thiophenylamide compounds"
Assay data:251 Active, 212 Activity ≤ 1 µM, 251 Tested
FABP Assay from US Patent US9708340: "Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors"
Assay data:45 Active, 27 Activity ≤ 1 µM, 48 Tested
Binding affinity to FABP4 (unknown origin) by microscale thermophoresis analysis
Assay data:2 Active, 3 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on